Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor – evidence for dosing flexibility - LEE, R. D.; VAKILY, M.; MULFORD, D.; WU, J.; ATKINSON, S. N. (Alimentary pharmacology & therapeutics, 2009)
Keywords: 2-Pyridinylmethylsulfinylbenzimidazoles - blood; 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacokinetics; Adolescent; Adult; Biological and medical sciences; Cross-Over Studies; Delayed-Action Preparations; Dexlansoprazole; Dietary Fats - pharmacokinetics; Digestive system; Fasting; Female; Food-Drug Interactions; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Lansoprazole; Male; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Proton Pump Inhibitors - blood; Proton Pump Inhibitors - pharmacokinetics; Young Adult; Human; Dexlansoprazole; Pharmacokinetic pharmacodynamic relationship; Controlled release form; Antiulcer agent; Flexibility; Posology; Proton pump inhibitor; Benzimidazole derivatives; Formulation; Dosage form; Clinical trial; Timing; Food